Skip to content
Disclosery

ABG-WTT Global Life Science Capital Partners GP Ltd: CBLL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ABG-WTT Global Life Science Capital Partners GP Ltd on CBLL, newest first. How the timeline and the estimate are built.

ABG-WTT Global Life Science Capital Partners GP Ltd held 275,328 CBLL shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 275,328 shares
    Change vs previous 13F -166,492 shares

    62.61% of the 13F portfolio, value $5,355,130.

    13F-HR 0001193125-26-352439 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 441,820 shares
    Change vs previous 13F 0 shares

    65.87% of the 13F portfolio, value $8,098,561.

    13F-HR 0001193125-26-227557 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 441,820 shares
    Change vs previous 13F -646,281 shares

    64.38% of the 13F portfolio, value $9,689,113.

    13F-HR 0001193125-26-055042 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,088,101 shares
    Change vs previous 13F 0 shares

    66.94% of the 13F portfolio, value $12,502,280.

    13F-HR 0001193125-25-283037 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,088,101 shares
    Change vs previous 13F 0 shares

    76.17% of the 13F portfolio, value $20,380,132.

    13F-HR 0000950123-25-008425 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,088,101 shares
    Change vs previous 13F 0 shares

    54.54% of the 13F portfolio, value $20,902,420.

    13F-HR 0000950123-25-005578 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,088,101 shares
    Change vs previous 13F not available

    64.42% of the 13F portfolio, value $28,160,054.

    13F-HR 0000950123-25-002368 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).